Natriumklorid Fresenius Kabi Leysir fyrir stungulyf 9 mg/ml Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

natriumklorid fresenius kabi leysir fyrir stungulyf 9 mg/ml

fresenius kabi ab - sodium chloride - leysir fyrir stungulyf - 9 mg/ml

Natriumklorid Fresenius Kabi Innrennslislyf, lausn 9 g/1000 ml Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

natriumklorid fresenius kabi innrennslislyf, lausn 9 g/1000 ml

fresenius kabi ab - sodium chloride - innrennslislyf, lausn - 9 g/1000 ml

Natriumklorid Baxter Viaflo 9 mg/ml Innrennslislyf, lausn 9 mg/ml Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

natriumklorid baxter viaflo 9 mg/ml innrennslislyf, lausn 9 mg/ml

baxter medical ab* - sodium chloride - innrennslislyf, lausn - 9 mg/ml

Natriumbikarbonat Meda Tafla 1 g Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

natriumbikarbonat meda tafla 1 g

viatris aps - sodium hydrogen carbonate - tafla - 1 g

Primovist Stungulyf, lausn í áfylltri sprautu 0,25 mmól/ml Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

primovist stungulyf, lausn í áfylltri sprautu 0,25 mmól/ml

bayer ab - sodium gadoxetate - stungulyf, lausn í áfylltri sprautu - 0,25 mmól/ml

Duraphat Tanndreifa 22,6 mg/ml Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

duraphat tanndreifa 22,6 mg/ml

colgate-palmolive a/s - sodium fluoride - tanndreifa - 22,6 mg/ml

Duraphat Tannpasta 5 mg/g Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

duraphat tannpasta 5 mg/g

colgate palmolive a/s - sodium fluoride - tannpasta - 5 mg/g

Nipruss Innrennslisstofn, lausn 60 mg Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

nipruss innrennslisstofn, lausn 60 mg

oresund pharma aps - sodium nitroprusside dihydrate - innrennslisstofn, lausn - 60 mg

Segluromet Den europeiske union - islandsk - EMA (European Medicines Agency)

segluromet

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - sykursýki, tegund 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Steglujan Den europeiske union - islandsk - EMA (European Medicines Agency)

steglujan

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic sýru, ofskömmtun fosfórinn einhýdrat - sykursýki, tegund 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - steglujan er ætlað í fullorðnir 18 ára og eldri með tegund 2 sykursýki sem viðbót til að fæði og æfa til að bæta blóðsykursstjórnun:þegar sjúklingar og/eða sulphonylurea (su) og einn af monocomponents af steglujan veita ekki fullnægjandi blóðsykursstjórnun. í sjúklinga þegar í meðferð með blöndu af ertugliflozin og ofskömmtun og að aðskilja töflur.